Interv Akut Kardiol. 2009;8(3):121-123
Introduction: Renal artery stenosis may result in an increase in blood pressure and the development of renal insufficiency; however, the
dilatation of stenosis using renal angioplasty has an indeterminate effect on the course of these conditions.
Objective: To assess the effect of percutaneous transluminal renal artery angioplasty (PTRA) on the course of hypertensive disease.
Methods: A retrospective study of the course of hypertensive disease in patients managed with PTRA at a single centre.
Results: In 26 patients, there was a significant decrease in the systolic (from 159 to 143 mm Hg, p = 0.02), diastolic (from 84 to 78 mm Hg,
p = 0.04) as well as mean blood pressures (from 108 to 100 mm Hg, p = 0.01), with a mean follow-up period of 8.6 months. The consumption
of antihypertensive drugs decreased significantly (from 3.56 to 2.38, p = 0.001). The group of patients with a favourable response to
PTRA (a decrease in the mean blood pressure by more than 10 mm Hg) was characterized by a significantly poorer initial management
of hypertension associated with an insignificantly higher number of antihypertensive drugs.
Conclusion: Angioplasty for atherosclerotic renal artery stenosis is beneficial in the management of hypertension, particularly in those
patients with poorly controlled hypertension and with a high consumption of antihypertensive drugs.
Published: July 15, 2009 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...